In this video, Motley Fool health-care analyst David Williamson discusses what investors should look for in Biogen Idec's upcoming earnings report, and what the Big Biotech has in store for 2013.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.